Sanara MedTech Inc. (SMTI)
USD 27.02
(-1.92%)
USD 27.02
(-1.92%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 73.87 Million USD | 21.03% |
| 2022 | 61.03 Million USD | 67.7% |
| 2021 | 36.39 Million USD | 270.4% |
| 2020 | 9.82 Million USD | -11.61% |
| 2019 | 11.11 Million USD | 265.45% |
| 2018 | 3.04 Million USD | 37.16% |
| 2017 | 2.21 Million USD | 2.14% |
| 2016 | 2.17 Million USD | 56.01% |
| 2015 | 1.39 Million USD | -7.11% |
| 2014 | 1.49 Million USD | 53.34% |
| 2013 | 977.14 Thousand USD | -29.88% |
| 2012 | 1.39 Million USD | -63.64% |
| 2011 | 3.83 Million USD | -43.5% |
| 2010 | 6.78 Million USD | 42.13% |
| 2009 | 4.77 Million USD | 3045.79% |
| 2008 | 151.71 Thousand USD | -62.61% |
| 2007 | 405.73 Thousand USD | -18.25% |
| 2006 | 496.28 Thousand USD | 92.5% |
| 2005 | 257.8 Thousand USD | 26.73% |
| 2004 | 203.42 Thousand USD | 0.0% |
| 2001 | 1.46 Million USD | 28.81% |
| 2000 | 1.13 Million USD | -21.64% |
| 1999 | 1.45 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 70.91 Million USD | -4.01% |
| 2024 Q2 | 73.38 Million USD | 3.49% |
| 2023 Q2 | 58.27 Million USD | -2.82% |
| 2023 FY | 73.87 Million USD | 21.03% |
| 2023 Q4 | 73.87 Million USD | -2.12% |
| 2023 Q3 | 75.47 Million USD | 29.51% |
| 2023 Q1 | 59.96 Million USD | -1.75% |
| 2022 FY | 61.03 Million USD | 67.7% |
| 2022 Q1 | 33.93 Million USD | -6.77% |
| 2022 Q2 | 46.47 Million USD | 36.97% |
| 2022 Q3 | 61.47 Million USD | 32.27% |
| 2022 Q4 | 61.03 Million USD | -0.72% |
| 2021 FY | 36.39 Million USD | 270.4% |
| 2021 Q1 | 39.01 Million USD | 297.08% |
| 2021 Q2 | 38.78 Million USD | -0.6% |
| 2021 Q4 | 36.39 Million USD | -4.04% |
| 2021 Q3 | 37.92 Million USD | -2.21% |
| 2020 FY | 9.82 Million USD | -11.61% |
| 2020 Q1 | 9.52 Million USD | -14.32% |
| 2020 Q2 | 10.09 Million USD | 5.94% |
| 2020 Q3 | 9.65 Million USD | -4.35% |
| 2020 Q4 | 9.82 Million USD | 1.81% |
| 2019 Q4 | 11.11 Million USD | 157.76% |
| 2019 Q1 | 3.25 Million USD | 7.05% |
| 2019 Q3 | 4.31 Million USD | 23.93% |
| 2019 Q2 | 3.48 Million USD | 6.87% |
| 2019 FY | 11.11 Million USD | 265.45% |
| 2018 Q1 | 2.17 Million USD | -2.01% |
| 2018 Q3 | 3.69 Million USD | 60.49% |
| 2018 Q4 | 3.04 Million USD | -17.56% |
| 2018 FY | 3.04 Million USD | 37.16% |
| 2018 Q2 | 2.29 Million USD | 5.79% |
| 2017 Q2 | 1.99 Million USD | -1.5% |
| 2017 Q3 | 2.1 Million USD | 5.89% |
| 2017 FY | 2.21 Million USD | 2.14% |
| 2017 Q1 | 2.02 Million USD | -6.93% |
| 2017 Q4 | 2.21 Million USD | 5.23% |
| 2016 Q1 | 1.52 Million USD | 9.6% |
| 2016 FY | 2.17 Million USD | 56.01% |
| 2016 Q2 | 1.56 Million USD | 2.84% |
| 2016 Q4 | 2.17 Million USD | 20.7% |
| 2016 Q3 | 1.79 Million USD | 14.67% |
| 2015 Q4 | 1.39 Million USD | -8.38% |
| 2015 Q2 | 1.46 Million USD | 13.65% |
| 2015 Q1 | 1.28 Million USD | -14.09% |
| 2015 FY | 1.39 Million USD | -7.11% |
| 2015 Q3 | 1.51 Million USD | 3.84% |
| 2014 FY | 1.49 Million USD | 53.34% |
| 2014 Q2 | 2.21 Million USD | -16.61% |
| 2014 Q1 | 2.65 Million USD | 171.77% |
| 2014 Q4 | 1.49 Million USD | -23.2% |
| 2014 Q3 | 1.95 Million USD | -11.9% |
| 2013 FY | 977.14 Thousand USD | -29.88% |
| 2013 Q3 | 1.18 Million USD | -13.96% |
| 2013 Q4 | 977.14 Thousand USD | -17.34% |
| 2013 Q1 | 1.61 Million USD | 16.19% |
| 2013 Q2 | 1.37 Million USD | -15.14% |
| 2012 FY | 1.39 Million USD | -63.64% |
| 2012 Q2 | 3.16 Million USD | -3.26% |
| 2012 Q3 | 2.76 Million USD | -12.65% |
| 2012 Q4 | 1.39 Million USD | -49.55% |
| 2012 Q1 | 3.26 Million USD | -14.7% |
| 2011 Q3 | 7.77 Million USD | -16.16% |
| 2011 Q4 | 3.83 Million USD | -50.72% |
| 2011 FY | 3.83 Million USD | -43.5% |
| 2011 Q2 | 9.27 Million USD | 11.68% |
| 2011 Q1 | 8.3 Million USD | 22.45% |
| 2010 FY | 6.78 Million USD | 42.13% |
| 2010 Q3 | 7.04 Million USD | 4.97% |
| 2010 Q4 | 6.78 Million USD | -3.68% |
| 2010 Q1 | 6.21 Million USD | 30.23% |
| 2010 Q2 | 6.7 Million USD | 7.94% |
| 2009 FY | 4.77 Million USD | 3045.79% |
| 2009 Q4 | 4.77 Million USD | -3.28% |
| 2009 Q3 | 4.93 Million USD | 2564.73% |
| 2009 Q2 | 185.17 Thousand USD | -34.53% |
| 2009 Q1 | 282.83 Thousand USD | 86.43% |
| 2008 Q1 | 1.26 Million USD | 210.63% |
| 2008 Q4 | 151.71 Thousand USD | -86.37% |
| 2008 Q3 | 1.11 Million USD | -6.36% |
| 2008 Q2 | 1.18 Million USD | -5.69% |
| 2008 FY | 151.71 Thousand USD | -62.61% |
| 2007 Q2 | 525.18 Thousand USD | 5.23% |
| 2007 Q3 | 427.22 Thousand USD | -18.65% |
| 2007 FY | 405.73 Thousand USD | -18.25% |
| 2007 Q4 | 405.73 Thousand USD | -5.03% |
| 2007 Q1 | 499.09 Thousand USD | 0.57% |
| 2006 Q1 | 260.96 Thousand USD | 1.22% |
| 2006 Q2 | 314.54 Thousand USD | 20.53% |
| 2006 Q4 | 496.28 Thousand USD | 49.14% |
| 2006 Q3 | 332.75 Thousand USD | 5.79% |
| 2006 FY | 496.28 Thousand USD | 92.5% |
| 2005 Q3 | 332.8 Thousand USD | -0.4% |
| 2005 Q2 | 334.14 Thousand USD | -16.26% |
| 2005 Q4 | 257.8 Thousand USD | -22.53% |
| 2005 FY | 257.8 Thousand USD | 26.73% |
| 2005 Q1 | 399 Thousand USD | 96.14% |
| 2004 Q2 | 413.1 Thousand USD | -17.87% |
| 2004 Q3 | 639.57 Thousand USD | 54.82% |
| 2004 FY | 203.42 Thousand USD | 0.0% |
| 2004 Q4 | 203.42 Thousand USD | -68.19% |
| 2004 Q1 | 502.96 Thousand USD | 0.0% |
| 2002 Q1 | 1.49 Million USD | 2.26% |
| 2001 Q2 | 1.26 Million USD | 1.04% |
| 2001 Q3 | 1.78 Million USD | 41.24% |
| 2001 Q4 | 1.46 Million USD | -18.03% |
| 2001 Q1 | 1.25 Million USD | 10.11% |
| 2001 FY | 1.46 Million USD | 28.81% |
| 2000 Q4 | 1.13 Million USD | -16.82% |
| 2000 Q1 | 1.54 Million USD | 0.0% |
| 2000 Q3 | 1.36 Million USD | -5.62% |
| 2000 FY | 1.13 Million USD | -21.64% |
| 2000 Q2 | 1.44 Million USD | -6.44% |
| 1999 FY | 1.45 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | 59.044% |
| AngioDynamics, Inc. | 317.67 Million USD | 76.746% |
| AtriCure, Inc. | 613.93 Million USD | 87.968% |
| Avinger, Inc. | 13.77 Million USD | -436.464% |
| Azenta, Inc. | 2.88 Billion USD | 97.44% |
| BioLife Solutions, Inc. | 412.71 Million USD | 82.101% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 99.366% |
| Daxor Corporation | 34.86 Million USD | -111.852% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | -155.45% |
| Femasys Inc. | 27.75 Million USD | -166.146% |
| GlucoTrack, Inc. | 4.9 Million USD | -1406.038% |
| Harvard Bioscience, Inc. | 137.36 Million USD | 46.223% |
| Hologic, Inc. | 9.15 Billion USD | 99.193% |
| ICU Medical, Inc. | 4.37 Billion USD | 98.313% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 99.522% |
| KORU Medical Systems, Inc. | 28.46 Million USD | -159.552% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | 78.698% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -1087.875% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -1087.875% |
| Masimo Corporation | 3.04 Billion USD | 97.571% |
| Microbot Medical Inc. | 8.32 Million USD | -787.128% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | 57.03% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | 96.823% |
| Nephros, Inc. | 11.86 Million USD | -522.807% |
| NovoCure Limited | 1.14 Billion USD | 93.555% |
| NEXGEL, Inc. | 9.95 Million USD | -642.051% |
| NEXGEL, Inc. | 9.95 Million USD | -642.051% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | 72.173% |
| OraSure Technologies, Inc. | 482.84 Million USD | 84.701% |
| Pro-Dex, Inc. | 54.21 Million USD | -36.268% |
| Pulse Biosciences, Inc. | 60.8 Million USD | -21.491% |
| Predictive Oncology Inc. | 14.41 Million USD | -412.38% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | -336.782% |
| QuidelOrtho Corporation | 8.56 Billion USD | 99.137% |
| Repligen Corporation | 2.82 Billion USD | 97.385% |
| STAAR Surgical Company | 488.69 Million USD | 84.884% |
| Sharps Technology, Inc. | 11.78 Million USD | -526.597% |
| Utah Medical Products, Inc. | 135.45 Million USD | 45.466% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 98.998% |
| Jin Medical International Ltd. | 32.9 Million USD | -124.509% |